In this video, the Multiple Sclerosis Association of America (MSAA) reminds everyone that people with MS don’t get a day off from the disease. They have to ... Read more
In this video, the Multiple Sclerosis Association of America (MSAA) reminds everyone that people with MS don’t get a day off from the disease. They have to ... Read more
Certain contrast agents used during magnetic resonance imaging (MRI) may accumulate in specific brain areas and contribute to disease duration and severity in patients with multiple ... Read more
In this video from My Journey with MS, Paul Baxter talks about some of the tests he had to undergo to be diagnosed with multiple sclerosis ... Read more
A long-term study underscores the potential benefits, especially in terms of relapses, of multiple sclerosis (MS) patients beginning treatment as soon as possible after symptoms appear — even before the disease ... Read more
The European Medicines Agency Pharmacovigilance Risk Assessment Committee (PRAC), responsible for assessing and monitoring safety issues for human medicines, completed a review on the risk for progressive ... Read more
A panel of neurologists from the U.K. and Ireland recently developed practical consensus guidelines for monitoring multiple sclerosis (MS) patients on natalizumab (Tysabri) therapy for the risk ... Read more
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more
